viomedo Provides Access to Innovative Treatment Methods

viomedoInformation overload is a common and significant problem with most existing clinical trial search platforms or applications. viomedo makes clinical trial information easily accessible to everybody based on a variety of criteria and by following patient-centric approaches. So far, viomedo online platform aggregates about close to 2.000 clinical trials conducted in Germany.

viomedo's founder Alexander Puschilov mentioned: "We are convinced, that everybody has the right to get the best possible therapy! This is why we’ve built viomedo to help patients discover and benefit from innovative treatment methods that were previously accessible only to a few lucky patients."

viomedo's reported main functionality and features are:

  • The platform aggregates information about close to 2.000 open trials in Germany that are both investigator and industry initiated that cover most known diseases. Patients can find the trial with a convenient search by their disease name or select a disease from a list.
  • Patients see the trial’s most relevant information in a way that they can understand. That empowers them to decide independently if the trial is worth participating in.
  • Patients can contact the closest clinical trial site location conveniently via viomedo. After a personal screening interview with the investigator they can make an educated decision about their participation.

viomedo's team developed the platform using the input, requirements and the feedback of the patients enrolled in clinical trials and the suggestions and expectations of healthcare professionals. "We want to bring transparency into the field of clinical-studies in order to connect patients and providers," Puschilov says. "And there is definitely a need for patient-centered platforms like viomedo. The collected clinical trials information represented on the platform combined with the platform's usability frames makes viomedo the central, most advanced and ambitious focal point for clinical research in Germany."

For further information, please visit:
http://www.viomedo.de

About viomedo
viomedo is a free platform, which aggregates and interprets information about clinical trials online. It was founded by Alexander Puschilov, Stefan Nietert and Tim Seithe in 2015 in Berlin. They have deep expertise in the fields of technology, medicine and digital health. It covers close to 2.000 trials that are open to patients in Germany. Because viomedo solves a great problem for patients and researchers alike, it has gathered support from leading clinicians.

Most Popular Now

Welcome Evo, Generative AI for the Genom…

Brian Hie runs the Laboratory of Evolutionary Design at Stanford, where he works at the crossroads of artificial intelligence and biology. Not long ago, Hie pondered a provocative question: If...

We could Soon Use AI to Detect Brain Tum…

A new paper in Biology Methods and Protocols, published by Oxford University Press, shows that scientists can train artificial intelligence (AI) models to distinguish brain tumors from healthy tissue. AI...

Telehealth Significantly Boosts Treatmen…

New research reveals a dramatic improvement in diagnosing and curing people living with hepatitis C in rural communities using both telemedicine and support from peers with lived experience in drug...

Research Study Shows the Cost-Effectiven…

Earlier research showed that primary care clinicians using AI-ECG tools identified more unknown cases of a weak heart pump, also called low ejection fraction, than without AI. New study findings...

AI can Predict Study Results Better than…

Large language models, a type of AI that analyses text, can predict the results of proposed neuroscience studies more accurately than human experts, finds a new study led by UCL...

New Guidance for Ensuring AI Safety in C…

As artificial intelligence (AI) becomes more prevalent in health care, organizations and clinicians must take steps to ensure its safe implementation and use in real-world clinical settings, according to an...

Remote Telemedicine Tool Found Highly Ac…

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a...

Philips Aims to Advance Cardiac MRI Tech…

Royal Philips (NYSE: PHG, AEX: PHIA) and Mayo Clinic announced a research collaboration aimed at advancing MRI for cardiac applications. Through this investigation, Philips and Mayo Clinic will look to...

New Study Reveals Why Organisations are …

The slow adoption of blockchain technology is partly driven by overhyped promises that often obscure the complex technological, organisational, and environmental challenges, according to research from the University of Surrey...

Deep Learning Model Accurately Diagnoses…

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary disease (COPD), according to a study published today in Radiology: Cardiothoracic...

Shape-Changing Device Helps Visually Imp…

Researchers from Imperial College London, working with the company MakeSense Technology and the charity Bravo Victor, have developed a shape-changing device called Shape that helps people with visual impairment navigate...

Bayer Acquires HiDoc Technologies and Ca…

Bayer is today announcing that it plans to acquire HiDoc Technologies GmbH in the first quarter of 2025 and to start commercialization of the digital health application, Cara Care®. Cara...